Di Jiang

606 total citations
10 papers, 527 citations indexed

About

Di Jiang is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Di Jiang has authored 10 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 7 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Di Jiang's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and RNA Interference and Gene Delivery (4 papers). Di Jiang is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and RNA Interference and Gene Delivery (4 papers). Di Jiang collaborates with scholars based in China and Macao. Di Jiang's co-authors include Ting Kang, Xingye Feng, Xiaoling Gao, Qingxiang Song, Hongzhuan Chen, Xuebiao Yao, Xinguo Jiang, Jun Chen, Quanyin Hu and Jun Chen and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Soft Matter.

In The Last Decade

Di Jiang

10 papers receiving 520 citations

Peers

Di Jiang
Yifan Tu China
Di Jiang
Citations per year, relative to Di Jiang Di Jiang (= 1×) peers Yifan Tu

Countries citing papers authored by Di Jiang

Since Specialization
Citations

This map shows the geographic impact of Di Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Jiang more than expected).

Fields of papers citing papers by Di Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Jiang. The network helps show where Di Jiang may publish in the future.

Co-authorship network of co-authors of Di Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Di Jiang. A scholar is included among the top collaborators of Di Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Jiang. Di Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Cuixia, Wenwen Tao, Di Jiang, et al.. (2024). Enzymatic functionalization of decellularized tilapia skin scaffolds with enhanced skin regeneration. Soft Matter. 20(16). 3508–3519. 1 indexed citations
2.
Wong, Ka Hong, et al.. (2023). Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy. Asian Journal of Pharmaceutical Sciences. 18(1). 100773–100773. 15 indexed citations
3.
Zhang, Dongdong, Feng Han, Kaili Wang, et al.. (2021). Green Electrospun Silk Fibroin Nanofibers Loaded with Cationic Ethosomes for Transdermal Drug Delivery. Chemical Research in Chinese Universities. 37(3). 488–495. 5 indexed citations
4.
Kang, Ting, Qianqian Zhu, Di Jiang, et al.. (2016). Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Biomaterials. 101. 60–75. 60 indexed citations
5.
Kang, Ting, Mengyin Jiang, Di Jiang, et al.. (2015). Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Molecular Pharmaceutics. 12(8). 2947–2961. 115 indexed citations
6.
Feng, Xingye, Xiaoling Gao, Ting Kang, et al.. (2015). Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG–PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy. Bioconjugate Chemistry. 26(8). 1850–1861. 32 indexed citations
7.
Feng, Xingye, Xuebiao Yao, Xiaoling Gao, et al.. (2015). Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy. ACS Applied Materials & Interfaces. 7(50). 27885–27899. 67 indexed citations
8.
Kang, Ting, Xiaoling Gao, Quanyin Hu, et al.. (2014). iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Biomaterials. 35(14). 4319–4332. 75 indexed citations
9.
Gu, Guangzhi, Quanyin Hu, Xingye Feng, et al.. (2014). PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Biomaterials. 35(28). 8215–8226. 84 indexed citations
10.
Hu, Quanyin, Xiaoling Gao, Ting Kang, et al.. (2013). CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Biomaterials. 34(37). 9496–9508. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026